Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Sepracor-Looks very promising -- Ignore unavailable to you. Want to Upgrade?

To: Thomas M. who wrote (1017)	7/21/1998 6:36:00 AM
From: billy d	Read Replies (2) \| Respond to of 10280

Thomas, Here is why the stock was going up yesterday. The Wall Street Journal reports that SEPR has signed an agreement with JNJ for Propulsid, a 1 Billion dollar heartburn drug. Terms were not disclosed but I believe SEPR will be receiving the high end of the range (10-15%) in royalties. This is one brilliant company. I know that on a valuation standpoint,relative to market cap, SEPR is priced quite high but announcements like this are the reason why you pay a premium for this stock. I would not be surprised to see a Prozac announcement in the near future. Congrats to all shareholders and SEPR.